Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
12 04 2023
Historique:
received: 12 08 2022
accepted: 11 04 2023
medline: 1 5 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: epublish

Résumé

A recent World Health Organization report states that at least 40% of all cancer cases may be preventable, with smoking, alcohol consumption, and obesity identified as three of the most important modifiable lifestyle factors. Given the significant decline in smoking rates, particularly within developed countries, other potentially modifiable risk factors for head and neck cancer warrant investigation. Obesity and related metabolic disorders such as type 2 diabetes (T2D) and hypertension have been associated with head and neck cancer risk in multiple observational studies. However, adiposity has also been correlated with smoking, with bias, confounding or reverse causality possibly explaining these findings. To overcome the challenges of observational studies, we conducted two-sample Mendelian randomization (inverse variance weighted [IVW] method) using genetic variants which were robustly associated with adiposity, glycaemic and blood pressure traits in genome-wide association studies (GWAS). Outcome data were taken from the largest available GWAS of 6034 oral and oropharyngeal cases, with 6585 controls. We found limited evidence of a causal effect of genetically proxied body mass index (BMI; OR IVW = 0.89, 95% CI 0.72-1.09, p = 0.26 per 1 standard deviation in BMI [4.81kg/m

Identifiants

pubmed: 37042641
doi: 10.7554/eLife.82674
pii: 82674
pmc: PMC10147379
doi:
pii:

Banques de données

dbGaP
['phs001202.v1.p1', 'phs000585.v2.p1']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/7
Pays : United Kingdom
Organisme : NIDCR NIH HHS
ID : R01 DE025712
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom

Informations de copyright

© 2023, Gormley et al.

Déclaration de conflit d'intérêts

MG, TD, ST, JT, AN, MP, DL, GD, RR, EV, CB No competing interests declared

Références

Hum Mol Genet. 2019 Apr 15;28(8):1322-1330
pubmed: 30561638
J Clin Epidemiol. 2008 Jul;61(7):646-53
pubmed: 18359190
BMJ. 2019 May 22;365:l1855
pubmed: 31122926
Sci Rep. 2020 Jun 24;10(1):10291
pubmed: 32581314
JAMA Netw Open. 2019 Mar 1;2(3):e190305
pubmed: 30848805
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Cancer Discov. 2013 Dec;3(12):1321-2
pubmed: 24327678
PLoS Genet. 2021 Apr 22;17(4):e1009525
pubmed: 33886544
PLoS Med. 2018 Sep 21;15(9):e1002654
pubmed: 30240442
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Nat Commun. 2021 Feb 8;12(1):995
pubmed: 33558525
Obes Facts. 2011;4(1):9-15
pubmed: 21372606
Eur J Epidemiol. 2019 Mar;34(3):259-265
pubmed: 30182324
Nature. 2015 Feb 12;518(7538):187-196
pubmed: 25673412
BMC Med. 2021 Jan 14;19(1):10
pubmed: 33441148
Int J Cancer. 2018 Sep 1;143(5):1029-1036
pubmed: 29536507
Br Dent J. 2018 Nov 9;225(9):867-873
pubmed: 30412558
Nat Hum Behav. 2021 Dec;5(12):1717-1730
pubmed: 34211149
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Psychol Med. 2020 Oct;50(14):2435-2443
pubmed: 31689377
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
BMC Med. 2022 Jan 31;20(1):40
pubmed: 35094705
N Engl J Med. 1991 Mar 14;324(11):739-45
pubmed: 1997840
PLoS Med. 2017 Sep 12;14(9):e1002383
pubmed: 28898252
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
BMJ. 2018 May 16;361:k1767
pubmed: 29769355
Diabetes Care. 2012 Nov;35(11):2402-11
pubmed: 23093685
Cancer Metab. 2021 Jun 3;9(1):25
pubmed: 34082811
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Tob Control. 2022 Mar;31(2):129-137
pubmed: 35241576
J Clin Oncol. 2015 Oct 10;33(29):3235-42
pubmed: 26351338
Int J Epidemiol. 2013 Oct;42(5):1497-501
pubmed: 24159078
Sci Rep. 2019 Jan 24;9(1):667
pubmed: 30679643
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Br J Sports Med. 2004 Jun;38(3):360-3; discussion 363
pubmed: 15155447
Nat Genet. 2018 Aug;50(8):1196
pubmed: 29967445
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
Br J Cancer. 2020 Oct;123(8):1336-1344
pubmed: 32728095
Cancer Biol Ther. 2003 Nov-Dec;2(6):630-5
pubmed: 14688466
Int J Cancer. 2020 May 15;146(10):2680-2693
pubmed: 31319002
Int J Epidemiol. 2018 Aug 1;47(4):1264-1278
pubmed: 29961852
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
J Appl Physiol (1985). 1992 Feb;72(2):787-95
pubmed: 1559959
Nat Genet. 2019 Feb;51(2):245-257
pubmed: 30643258
Nat Genet. 2020 Jul;52(7):680-691
pubmed: 32541925
Int J Epidemiol. 2016 Dec 1;45(6):1961-1974
pubmed: 27616674
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
Mol Cell. 2015 Nov 19;60(4):514-23
pubmed: 26590711
Int J Epidemiol. 2015 Apr;44(2):673-81
pubmed: 26050257
Hypertension. 2012 Apr;59(4):802-10
pubmed: 22353615
Bioinformatics. 2015 Feb 1;31(3):418-20
pubmed: 25316677
Oral Oncol. 2015 Apr;51(4):332-40
pubmed: 25650271
JAMA Otolaryngol Head Neck Surg. 2014 Aug;140(8):746-53
pubmed: 25058016
PLoS One. 2021 Jun 7;16(6):e0252872
pubmed: 34097712
Clin Otolaryngol. 2018 Aug;43(4):999-1003
pubmed: 29770611
Nat Genet. 2016 Dec;48(12):1544-1550
pubmed: 27749845
Hum Mol Genet. 2019 Jan 1;28(1):166-174
pubmed: 30239722
Hum Mol Genet. 2018 Aug 1;27(R2):R195-R208
pubmed: 29771313
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):895-904
pubmed: 28183827
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50
pubmed: 19190158
J Intern Med. 2020 Apr;287(4):435-447
pubmed: 31912596

Auteurs

Mark Gormley (M)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Bristol Dental Hospital and School, University of Bristol, Bristol, United Kingdom.

Tom Dudding (T)

Bristol Dental Hospital and School, University of Bristol, Bristol, United Kingdom.

Steven J Thomas (SJ)

Bristol Dental Hospital and School, University of Bristol, Bristol, United Kingdom.

Jessica Tyrrell (J)

University of Exeter Medical School, RILD Building, RD&E Hospital, Exeter, United Kingdom.

Andrew R Ness (AR)

University Hospitals Bristol and Weston NHS Foundation Trust National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.

Miranda Pring (M)

Bristol Dental Hospital and School, University of Bristol, Bristol, United Kingdom.

Danny Legge (D)

Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

George Davey Smith (G)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Rebecca C Richmond (RC)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Emma E Vincent (EE)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Caroline Bull (C)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH